Mert Aktar's most recent trade in Kyverna Therapeutics Inc. was a trade of 20,582 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kyverna Therapeutics Inc | Mert Aktar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2026 | 20,582 | 20,582 | - | - | Stock Option (right to buy) | |
| Kyverna Therapeutics Inc | Mert Aktar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2026 | 5,093 | 21,727 | - | 0 | Common Stock | |
| Kyverna Therapeutics Inc | Mert Aktar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 65,351 | 65,351 | - | - | Stock Option (right to buy) | |
| Kyverna Therapeutics Inc | Mert Aktar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 16,634 | 16,634 | - | 0 | Common Stock | |
| Kyverna Therapeutics Inc | Mert Aktar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2024 | 87,741 | 87,741 | - | - | Stock Option (right to buy) |